Click for best price
Kidney Cancer Therapeutics Market Size, Share 2023
Kidney cancer is?cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Therapeutics. This report contains market size and forecasts of Kidney Cancer Therapeutics in global, including the following market information:
Global Kidney Cancer Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Kidney Cancer Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Surgery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Kidney Cancer Therapeutics include Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer and Exelixis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
we surveyed the Kidney Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Cancer Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Surgery
Immunotherapy
Targeted Therapy
Other
Global Kidney Cancer Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
Renal Cell Carcinoma
Renal Pelvis Cancer
Other
Global Kidney Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Kidney Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Aveo Pharmaceuticals
Bayer
Exelixis
Eisai
Outline of Major Chapters:
Chapter 1: Introduces the definition of Kidney Cancer Therapeutics, market overview.
Chapter 2: Global Kidney Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Kidney Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Kidney Cancer Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Kidney Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Cancer Therapeutics Overall Market Size
2.1 Global Kidney Cancer Therapeutics Market Size: 2022 VS 2029
2.2 Global Kidney Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Kidney Cancer Therapeutics Players in Global Market
3.2 Top Global Kidney Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Kidney Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Kidney Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Kidney Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Kidney Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Kidney Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Kidney Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Kidney Cancer Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Surgery
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.1.5 Other
4.2 By Type - Global Kidney Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Kidney Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Kidney Cancer Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Kidney Cancer Therapeutics Market Size, 2022 & 2029
5.1.2 Renal Cell Carcinoma
5.1.3 Renal Pelvis Cancer
5.1.4 Other
5.2 By Application - Global Kidney Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Kidney Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Kidney Cancer Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Kidney Cancer Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Kidney Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Kidney Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Kidney Cancer Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Kidney Cancer Therapeutics Revenue, 2018-2029
6.3.2 US Kidney Cancer Therapeutics Market Size, 2018-2029
6.3.3 Canada Kidney Cancer Therapeutics Market Size, 2018-2029
6.3.4 Mexico Kidney Cancer Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Kidney Cancer Therapeutics Revenue, 2018-2029
6.4.2 Germany Kidney Cancer Therapeutics Market Size, 2018-2029
6.4.3 France Kidney Cancer Therapeutics Market Size, 2018-2029
6.4.4 U.K. Kidney Cancer Therapeutics Market Size, 2018-2029
6.4.5 Italy Kidney Cancer Therapeutics Market Size, 2018-2029
6.4.6 Russia Kidney Cancer Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Kidney Cancer Therapeutics Market Size, 2018-2029
6.4.8 Benelux Kidney Cancer Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Kidney Cancer Therapeutics Revenue, 2018-2029
6.5.2 China Kidney Cancer Therapeutics Market Size, 2018-2029
6.5.3 Japan Kidney Cancer Therapeutics Market Size, 2018-2029
6.5.4 South Korea Kidney Cancer Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Kidney Cancer Therapeutics Market Size, 2018-2029
6.5.6 India Kidney Cancer Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Kidney Cancer Therapeutics Revenue, 2018-2029
6.6.2 Brazil Kidney Cancer Therapeutics Market Size, 2018-2029
6.6.3 Argentina Kidney Cancer Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue, 2018-2029
6.7.2 Turkey Kidney Cancer Therapeutics Market Size, 2018-2029
6.7.3 Israel Kidney Cancer Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Kidney Cancer Therapeutics Market Size, 2018-2029
6.7.5 UAE Kidney Cancer Therapeutics Market Size, 2018-2029
7 Kidney Cancer Therapeutics Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Kidney Cancer Therapeutics Major Product Offerings
7.1.4 Merck Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Kidney Cancer Therapeutics Major Product Offerings
7.2.4 Novartis Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Kidney Cancer Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Kidney Cancer Therapeutics Major Product Offerings
7.4.4 Pfizer Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Kidney Cancer Therapeutics Major Product Offerings
7.5.4 Roche Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Kidney Cancer Therapeutics Major Product Offerings
7.6.4 Amgen Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Aveo Pharmaceuticals
7.7.1 Aveo Pharmaceuticals Company Summary
7.7.2 Aveo Pharmaceuticals Business Overview
7.7.3 Aveo Pharmaceuticals Kidney Cancer Therapeutics Major Product Offerings
7.7.4 Aveo Pharmaceuticals Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Aveo Pharmaceuticals Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Company Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Kidney Cancer Therapeutics Major Product Offerings
7.8.4 Bayer Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Bayer Key News & Latest Developments
7.9 Exelixis
7.9.1 Exelixis Company Summary
7.9.2 Exelixis Business Overview
7.9.3 Exelixis Kidney Cancer Therapeutics Major Product Offerings
7.9.4 Exelixis Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Exelixis Key News & Latest Developments
7.10 Eisai
7.10.1 Eisai Company Summary
7.10.2 Eisai Business Overview
7.10.3 Eisai Kidney Cancer Therapeutics Major Product Offerings
7.10.4 Eisai Kidney Cancer Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Eisai Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Kidney Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Kidney Cancer Therapeutics Market Drivers in Global Market
Table 3. Kidney Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Kidney Cancer Therapeutics in Global Market
Table 5. Top Kidney Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Kidney Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Kidney Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Kidney Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Kidney Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Kidney Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Kidney Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Kidney Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Kidney Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Kidney Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Kidney Cancer Therapeutics Product Offerings
Table 32. Merck Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Kidney Cancer Therapeutics Product Offerings
Table 36. Novartis Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Kidney Cancer Therapeutics Product Offerings
Table 40. Bristol-Myers Squibb Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Kidney Cancer Therapeutics Product Offerings
Table 44. Pfizer Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Kidney Cancer Therapeutics Product Offerings
Table 48. Roche Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Kidney Cancer Therapeutics Product Offerings
Table 52. Amgen Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Aveo Pharmaceuticals Company Summary
Table 55. Aveo Pharmaceuticals Kidney Cancer Therapeutics Product Offerings
Table 56. Aveo Pharmaceuticals Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Aveo Pharmaceuticals Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Kidney Cancer Therapeutics Product Offerings
Table 60. Bayer Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. Exelixis Company Summary
Table 63. Exelixis Kidney Cancer Therapeutics Product Offerings
Table 64. Exelixis Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Exelixis Key News & Latest Developments
Table 66. Eisai Company Summary
Table 67. Eisai Kidney Cancer Therapeutics Product Offerings
Table 68. Eisai Kidney Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Eisai Key News & Latest Developments
List of Figures
Figure 1. Kidney Cancer Therapeutics Segment by Type in 2022
Figure 2. Kidney Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Kidney Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Kidney Cancer Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Kidney Cancer Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Kidney Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Kidney Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Kidney Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Kidney Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aveo Pharmaceuticals Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bayer Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Exelixis Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eisai Kidney Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
